The Global Investor Forum took place on March 18 in order to facilitate private capital match with promising investment-ready Life Sciences, MedTech, E-health and AI start-ups, scape-ups and tech transfer opportunities. It was the first time it took place as a virtual edition, in which 30 promising start-up and scale-up companies presented their company and innovation online to a jury and other key players in the named fields.
The Global Investor Forum creates a powerful network of leading biomed entrepreneurs, formal and informal investors, physician key-opinion leaders and innovation executives, offering an excellent platform for leading investors, start-up founders and CEO’s of innovative companies to discuss investment opportunities, to expand and strengthen busines network for future partnerships.
As much as four companies from the Kadans Community gave a pitch during the online Forum. Protinhi Therapeutics, Enzyre, ATRO Medical and Pleco Therapeutic have presented themselves to the audience of leading investors and other key players in Life Sciences & Health.
Protinhi talked about the development of novel drugs acting as protease inhibitors to treat a wide range of illnesses. Currently they focus on viral infectious diseases, including dengue fever, Zika, West Nile virus, chikungunya and corona virus. ATRO Medical addressed the development of the Trammpolin Meniscus Prosthesis. Enzyre elaborated on their development of a near patient diagnostics platform focused on blood coagulation. The fourth company Pleco Therapeutic gave a pitch on the development of new medicines that generate a break-through improvement in the survival rate of cancer patients.
We are proud two of the four companies from our community have qualified for the semi-finals. Enzyre and Pleco Therapeutic are two of the best nine pitches. They get the chance to pitch again in front of an online jury to qualify for the finals at Innovation for Health. During this semi-final of the start-up pitching contest on April 8, the audience gets the chance to co-decide which of the nine semi-finalists belong to the three most promising start-up companies and who get to pitch during the finale on April 15 at Innovation for Health 2021!
Kadans ecosystem
Furthermore, our senior ecosystem manager, Tom Straeter, got to present the ecosystem of Kadans during the programme section “Presenting hubs & ecosystems in Life Sciences & Health”. Here he presented in front of the many start-ups, scale-ups, investors and other persons and organizations from the Dutch Life Sciences & Health sector Kadans Science Partner as a mature and distinguished partner in the Life Sciences & Health ecosystem. Over the past few years, Kadans has built an extensive network of knowledge-intensive organizations, including many life sciences activities, on top campuses and science parks in Europe. This network is set to expand significantly in the coming years. This enables us to connect the organizations that are part of this network, the Kadans Community, and offer them access to new knowledge, the market, talent and required facilities. This not only provides the Kadans Community with modern and flexible accommodation on science parks and campuses throughout Europe, but also with a variety of additional ecosystem services enabling them to be more innovative and successful.
Partners can also join the Kadans network and gain access to many innovative life sciences start-ups on multiple campuses in the Netherlands and Europe. Interested to know more about what Kadans Science Partner can offer you? Please contact us!